Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1)
暂无分享,去创建一个
D. Keppler | A. Nies | M. Brom | E. Herrmann
[1] G. Ciarimboli. Organic cation transporters , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[2] H. Koepsell,et al. Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications , 2007, Pharmaceutical Research.
[3] D. Keppler,et al. The apical conjugate efflux pump ABCC2 (MRP2) , 2007, Pflügers Archiv - European Journal of Physiology.
[4] K. Ueda,et al. Human MDR1 and MRP1 Recognize Berberine as Their Transport Substrate , 2007, Bioscience, biotechnology, and biochemistry.
[5] N. Nakamura,et al. Pharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass Spectrometry , 2006, Drug Metabolism and Disposition.
[6] S. Masuda,et al. Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family) , 2006, Journal of Pharmacology and Experimental Therapeutics.
[7] Shuzhong Zhang,et al. Organic cation transporters are determinants of oxaliplatin cytotoxicity. , 2006, Cancer research.
[8] D. Keppler,et al. ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. , 2005, Cancer research.
[9] Hiroshi Omote,et al. A human transporter protein that mediates the final excretion step for toxic organic cations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Keppler,et al. Vectorial Transport of the Peptide CCK-8 by Double-Transfected MDCKII Cells Stably Expressing the Organic Anion Transporter OATP1B3 (OATP8) and the Export Pump ABCC2 , 2005, Journal of Pharmacology and Experimental Therapeutics.
[11] T. Tsai,et al. Hepatobiliary excretion of berberine. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[12] Andreas Rolfs,et al. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins , 2004, Pflügers Archiv.
[13] Chava Kimchi-Sarfaty,et al. P-glycoprotein: from genomics to mechanism , 2003, Oncogene.
[14] Yuichi Sugiyama,et al. ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics* , 2003, Journal of Biological Chemistry.
[15] C. Shim,et al. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. , 2002, Journal of pharmaceutical sciences.
[16] J. P. Fawcett,et al. The involvement of P-glycoprotein in berberine absorption. , 2002, Pharmacology & toxicology.
[17] Heinz Bönisch,et al. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 , 2002, British journal of pharmacology.
[18] Hideyuki Saito,et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. , 2002, Journal of the American Society of Nephrology : JASN.
[19] D. Keppler,et al. Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2). , 2002, European journal of biochemistry.
[20] H. Endou,et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. , 2002, Journal of Pharmacology and Experimental Therapeutics.
[21] T. Abe,et al. Transcellular Transport of Organic Anions Across a Double-transfected Madin-Darby Canine Kidney II Cell Monolayer Expressing Both Human Organic Anion-transporting Polypeptide (OATP2/SLC21A6) and Multidrug Resistance-associated Protein 2 (MRP2/ABCC2)* , 2002, The Journal of Biological Chemistry.
[22] D. Keppler,et al. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. , 2001, Molecular pharmacology.
[23] M. Iwunze. Media Influence on the Enhancement of the Fluorescence of Berberine Hydrochloride , 2000 .
[24] S. Antonarakis,et al. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .
[25] J. Chaires,et al. Sequence and structural selectivity of nucleic acid binding ligands. , 1999, Biochemistry.
[26] S. Binkley,et al. Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities. , 1999, The Journal of pharmacology and experimental therapeutics.
[27] D. Gründemann,et al. Selective substrates for non-neuronal monoamine transporters. , 1999, Molecular pharmacology.
[28] D. Keppler,et al. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. , 1999, Journal of the American Society of Nephrology : JASN.
[29] D. Keppler,et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. , 1999, Molecular pharmacology.
[30] H. Koepsell,et al. Membrane localization of the electrogenic cation transporter rOCT1 in rat liver. , 1998, Biochemical and biophysical research communications.
[31] K. Giacomini,et al. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). , 1998, The Journal of pharmacology and experimental therapeutics.
[32] F. Lang,et al. Cloning and characterization of two human polyspecific organic cation transporters. , 1997, DNA and cell biology.
[33] K. Giacomini,et al. Cloning and functional expression of a human liver organic cation transporter. , 1997, Molecular pharmacology.
[34] A. Schmidt,et al. Primary Structure and Functional Expression of the Apical Organic Cation Transporter from Kidney Epithelial LLC-PK1Cells* , 1997, The Journal of Biological Chemistry.
[35] A. Dantzig,et al. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. , 1996, Cancer research.
[36] M. Takano,et al. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. , 1996, Biochemical and biophysical research communications.
[37] C. M. Chen,et al. Determination of berberine in plasma, urine and bile by high-performance liquid chromatography. , 1995, Journal of chromatography. B, Biomedical applications.
[38] H. Koepsell,et al. Drug excretion mediated by a new prototype of polyspecific transporter , 1994, Nature.
[39] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[40] N. K. Dutta,et al. Absorption, distribution and excretion of berberine. , 1969, The Indian journal of medical research.
[41] Lenka Gryčová,et al. Quaternary protoberberine alkaloids. , 2007, Phytochemistry.
[42] D. Gründemann,et al. Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency. , 2006, Handbook of experimental pharmacology.
[43] K. Giacomini,et al. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. , 2006, Journal of pharmaceutical sciences.
[44] S. Masuda,et al. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. , 2005, Drug metabolism and pharmacokinetics.
[45] A. Dantzig,et al. Modulation of P‐glycoprotein but not MRP1‐ or BCRP‐mediated drug resistance by LY335979 , 2003, International journal of cancer.
[46] Da-yuan Zhu,et al. Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers' urine after oral administration. , 2002, Acta pharmacologica Sinica.
[47] D. Keppler,et al. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[48] I. Pastan,et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.